Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Striatal transcriptome of a mouse model of ADHD reveals a pattern of synaptic remodeling.

Sorokina AM, Saul M, Goncalves TM, Gogola JV, Majdak P, Rodriguez-Zas SL, Rhodes JS.

PLoS One. 2018 Aug 15;13(8):e0201553. doi: 10.1371/journal.pone.0201553. eCollection 2018.

2.

Pharmacological analysis of zebrafish lphn3.1 morphant larvae suggests that saturated dopaminergic signaling could underlie the ADHD-like locomotor hyperactivity.

Lange M, Froc C, Grunwald H, Norton WHJ, Bally-Cuif L.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jun 8;84(Pt A):181-189. doi: 10.1016/j.pnpbp.2018.02.010. Epub 2018 Feb 26.

3.

Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD.

Myer NM, Boland JR, Faraone SV.

Mol Psychiatry. 2017 Dec 12. doi: 10.1038/mp.2017.234. [Epub ahead of print]

PMID:
29230023
4.

Further replication of the synergistic interaction between LPHN3 and the NTAD gene cluster on ADHD and its clinical course throughout adulthood.

Kappel DB, Schuch JB, Rovaris DL, da Silva BS, Cupertino RB, Winkler C, Teche SP, Vitola ES, Karam RG, Rohde LA, Bau CHD, Grevet EH, Mota NR.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):120-127. doi: 10.1016/j.pnpbp.2017.06.011. Epub 2017 Jun 15.

5.

Common and specific genes and peripheral biomarkers in children and adults with attention-deficit/hyperactivity disorder.

Bonvicini C, Faraone SV, Scassellati C.

World J Biol Psychiatry. 2018 Mar;19(2):80-100. doi: 10.1080/15622975.2017.1282175. Epub 2017 Feb 24. Review.

PMID:
28097908
6.

An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.

Martinez AF, Abe Y, Hong S, Molyneux K, Yarnell D, Löhr H, Driever W, Acosta MT, Arcos-Burgos M, Muenke M.

Biol Psychiatry. 2016 Dec 15;80(12):943-954. doi: 10.1016/j.biopsych.2016.06.026. Epub 2016 Jul 14.

7.

ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study.

Acosta MT, Swanson J, Stehli A, Molina BS; MTA Team, Martinez AF, Arcos-Burgos M, Muenke M.

Mol Genet Genomic Med. 2016 Jul 18;4(5):540-7. doi: 10.1002/mgg3.230. eCollection 2016 Sep.

8.

Behavioral and transcriptomic profiling of mice null for Lphn3, a gene implicated in ADHD and addiction.

Orsini CA, Setlow B, DeJesus M, Galaviz S, Loesch K, Ioerger T, Wallis D.

Mol Genet Genomic Med. 2016 Mar 4;4(3):322-43. doi: 10.1002/mgg3.207. eCollection 2016 May.

9.

Developmental exposure to acetaminophen does not induce hyperactivity in zebrafish larvae.

Reuter I, Knaup S, Romanos M, Lesch KP, Drepper C, Lillesaar C.

J Neural Transm (Vienna). 2016 Aug;123(8):841-8. doi: 10.1007/s00702-016-1556-z. Epub 2016 Apr 26.

PMID:
27116683
10.

Attention deficit hyperactivity disorder: genetic association study in a cohort of Spanish children.

Gomez-Sanchez CI, Riveiro-Alvarez R, Soto-Insuga V, Rodrigo M, Tirado-Requero P, Mahillo-Fernandez I, Abad-Santos F, Carballo JJ, Dal-Ré R, Ayuso C.

Behav Brain Funct. 2016 Jan 8;12(1):2. doi: 10.1186/s12993-015-0084-6.

11.

Linkage and association analysis of ADHD endophenotypes in extended and multigenerational pedigrees from a genetic isolate.

Mastronardi CA, Pillai E, Pineda DA, Martinez AF, Lopera F, Velez JI, Palacio JD, Patel H, Easteal S, Acosta MT, Castellanos FX, Muenke M, Arcos-Burgos M.

Mol Psychiatry. 2016 Oct;21(10):1434-40. doi: 10.1038/mp.2015.172. Epub 2015 Nov 24.

12.

Structural and Mechanistic Insights into the Latrophilin3-FLRT3 Complex that Mediates Glutamatergic Synapse Development.

Ranaivoson FM, Liu Q, Martini F, Bergami F, von Daake S, Li S, Lee D, Demeler B, Hendrickson WA, Comoletti D.

Structure. 2015 Sep 1;23(9):1665-1677. doi: 10.1016/j.str.2015.06.022. Epub 2015 Jul 30.

13.

Structural Basis of Latrophilin-FLRT-UNC5 Interaction in Cell Adhesion.

Lu YC, Nazarko OV, Sando R 3rd, Salzman GS, Li NS, Südhof TC, Araç D.

Structure. 2015 Sep 1;23(9):1678-1691. doi: 10.1016/j.str.2015.06.024. Epub 2015 Jul 30.

14.

Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder.

Sánchez-Mora C, Richarte V, Garcia-Martínez I, Pagerols M, Corrales M, Bosch R, Vidal R, Viladevall L, Casas M, Cormand B, Ramos-Quiroga JA, Ribasés M.

Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):480-491. doi: 10.1002/ajmg.b.32340. Epub 2015 Jul 14.

PMID:
26174753
15.

LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study.

Bruxel EM, Salatino-Oliveira A, Akutagava-Martins GC, Tovo-Rodrigues L, Genro JP, Zeni CP, Polanczyk GV, Chazan R, Schmitz M, Arcos-Burgos M, Rohde LA, Hutz MH.

Genes Brain Behav. 2015 Jun;14(5):419-27. doi: 10.1111/gbb.12224.

16.

ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila.

van der Voet M, Harich B, Franke B, Schenck A.

Mol Psychiatry. 2016 Apr;21(4):565-73. doi: 10.1038/mp.2015.55. Epub 2015 May 12.

17.

Association of LPHN3 rs6551665 A/G polymorphism with attention deficit and hyperactivity disorder in Korean children.

Hwang IW, Lim MH, Kwon HJ, Jin HJ.

Gene. 2015 Jul 15;566(1):68-73. doi: 10.1016/j.gene.2015.04.033. Epub 2015 Apr 12.

PMID:
25871512
18.

The molecular genetic architecture of attention deficit hyperactivity disorder.

Hawi Z, Cummins TD, Tong J, Johnson B, Lau R, Samarrai W, Bellgrove MA.

Mol Psychiatry. 2015 Mar;20(3):289-97. doi: 10.1038/mp.2014.183. Epub 2015 Jan 20. Review.

PMID:
25600112
19.

Association of SNAP-25, SLC6A2, and LPHN3 with OROS methylphenidate treatment response in attention-deficit/hyperactivity disorder.

Song J, Kim SW, Hong HJ, Lee MG, Lee BW, Choi TK, Lee SH, Yook KH.

Clin Neuropharmacol. 2014 Sep-Oct;37(5):136-41. doi: 10.1097/WNF.0000000000000045.

PMID:
25229170
20.

LPHN3, a presynaptic adhesion-GPCR implicated in ADHD, regulates the strength of neocortical layer 2/3 synaptic input to layer 5.

O'Sullivan ML, Martini F, von Daake S, Comoletti D, Ghosh A.

Neural Dev. 2014 Apr 17;9:7. doi: 10.1186/1749-8104-9-7.

Supplemental Content

Loading ...
Support Center